CompoAtlas

Sexotic (Paziņots 2010.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000207/2010
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
Z un Z, SIA
Manufacturer
Joydivision International AG
Origin
Latvija
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
6ml dienā
Published pack size
flakons 30ml
Published packaging
flakons 30ml

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
Guarānas ekstraktsplants ; Guarānas ekstrakts ; Paullinia cupana ; 225 ; mgpaullinia cupanaPlant
Cietķērsas jeb Makas ekstraktsplants ; Cietķērsas jeb Makas ekstrakts ; Lepidium meyenii ; 129 ; mglepidium meyeniiPlant
Gvajaki koksnes ekstraktsplants ; Gvajaki koksnes ekstrakts ; Guaiacum officinale ; 90 ; mgguaiacum officinalePlant
Kajēnas pipara ekstraktsplants ; Kajēnas pipara ekstrakts ; Capsicum annum ; 18 ; mgNot recognisedRole not identified
ŪdensotherIngredients ; ŪdensNot recognisedRole not identified
GlikozeotherIngredients ; GlikozeNot recognisedRole not identified
Glicerīns (E422)otherIngredients ; Glicerīns (E422)Listed as food additive E 422 (EU Union list)Role not identified
AlkoholsotherIngredients ; AlkoholsNot recognisedRole not identified
AromatizētājsotherIngredients ; AromatizētājsNot recognisedRole not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Vācija

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Cietķērsas jeb Makas ekstrakts
    Read the warning, when it applies and the studies cited

    Maca - Lepidium Meyenii

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Applies to products providing 0.6 g or more dried root/hypocotyl, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a blood pressure condition (Valentova et al. 2008).

    Sources cited by Health Canada (1)
    • Valentova K, Stejskal D, Bartek J, Dvoráckova S, Kren V, Ulrichova J, Simanek V. Maca (Lepidium meyenii) and yacon (Smallanthus sonchifolius) in combination with silymarin as food supplements: in vivo safety assessment. Food and Chemical Toxicology 2008;46(3):1006-1013. PubMed Randomised trial

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).

    Sources cited by Health Canada (2)
    • Dording CM, Fsher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neuroscience Therapy and Therapeutics 2008;14(3):182-191. PubMed Randomised trial
    • Gonzales GF, Gonzales-Castaneda GC. The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii). Evidence Based Complementary Alternative Medicine 2009;6(3):315-316. PubMed

    Condition of application: Healthy mood balance; Sexual health.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression (Brotto 2010; Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).

    Sources cited by Health Canada (3)
    • Brotto LA. The DSM diagnostic criteria for hypoactive sexual desire disorder in women. Archives of Sexual Behavior 2010;39(2):221-239. PubMed Review article
    • Dording CM, Fsher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neuroscience Therapy and Therapeutics 2008;14(3):182-191. PubMed Randomised trial
    • Gonzales GF, Gonzales-Castaneda GC. The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii). Evidence Based Complementary Alternative Medicine 2009;6(3):315-316. PubMed

    Health Canada monograph dated 27 September 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Sexotic (Paziņots 2010.)”, https://compoatlas.com/en/supplements/latvia/2712-sexotic-pazinots-2010, updated 28 October 2026.

Enter to analyse, Shift+Enter for a new line